9th RNA-Targeted Drug Discovery and Development Summit
8 8 people viewed this event.
RNA-targeting small molecules are rapidly gaining therapeutic traction, underscored by clinical advances including ReviR Therapeutics first participant dosed in a Phase 1 study of RTX-117 and Remix Therapeutics reporting positive Phase 1/2 data for REM-422.
Date and Time: Tuesday, 10 November 2026 at 07:00 – Thursday, 12 November 2026 at 16:30
Venue details: Hotel Commonwealth, 500 Commonwealth Avenue, Boston, Massachusetts, 02215, United States
Prices:
USD 2699.00 – USD 5297.00
Event Organizer: Hanson Wade